(American College of Rheumatology) The American College of Rheumatology (ACR) today applauded the leadership of Rep. David McKinley (R-WV) and Rep. G.K. Butterfield (D-NC) in reintroducing H.R. 2999, the Patients' Access to Treatment Act (PATA). The bipartisan legislation would limit cost-sharing requirements for medications placed on specialty insurance tiers and make innovative and necessary therapies more accessible to Americans living with rheumatic diseases by reducing excessive out-of-pocket expenses.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2rLoSy7
No comments:
Post a Comment